09 May 2025
09 May 2025
The FDA鈥檚 agency-wide genAI rollout is being led by Jeremy Walsh, the recently appointed chief AI officer.
Bavarian Nordic faced a challenging close to 2024, with Q3 revenue falling 26% compared to the same interval in 2023.
It is vital for biotech companies to run the right clinical trial and not cut costs with trial design or patient recruitment, the executive said.
The funding round was spearheaded by Earlybird Venture Capital and Sofinnova Partners.
The controlled cell line combined with Recipharm鈥檚 AAV manufacturing platform is said to allow for consistent and scalable high yields at several scales, accommodating a wide array of serotypes.
The partnership has enabled Viralgen to scale up and complete a GMP trial material batch of Trogenix's therapy.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
